{"name": "BioXell",
 "permalink": "bioxell",
 "crunchbase_url": "http://www.crunchbase.com/company/bioxell",
 "homepage_url": "http://www.bioxell.com",
 "blog_url": "",
 "blog_feed_url": "http://www.cosmopharmaceuticals.com/news/press.aspx",
 "twitter_username": "cosmopharma",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2002,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@bioxell.com",
 "phone_number": "+39 02 21049 51",
 "description": "",
 "created_at": "Thu Nov 19 02:57:07 UTC 2009",
 "updated_at": "Sun Mar 31 12:08:24 UTC 2013",
 "overview": "\u003Cp\u003EBioXell was founded in 2002 as a spinout of Roche Milano Ricerche, a leading biomedical research institute created ten years earlier that focused on chronic inflammatory disease and autoimmunity.\u003C/p\u003E\n\n\u003Cp\u003EThe idea to create BioXell originated with Francesco Sinigaglia, founder and director of the Milan-based research institute, following a scientific career path that took him to the University College in London, the Basel Institute of Immunology and the Hoffmann-La Roche research units in Basel. Dr. Sinigaglia, former CEO, approached Roche with his challenging project and a year later BioXell was spun off, with $22m invested by MPM Capital, Index Ventures and Life Science Partners.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       49],
      "assets/images/resized/0006/6751/66751v1-max-150x150.png"],
     [[181,
       60],
      "assets/images/resized/0006/6751/66751v1-max-250x250.png"],
     [[181,
       60],
      "assets/images/resized/0006/6751/66751v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Niels",
      "last_name": "Ackermann",
      "permalink": "niels-ackermann",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Laurence",
      "last_name": "H. Skillern",
      "permalink": "laurence-h-skillern",
      "image": null}},
   {"is_past": false,
    "title": "CAO",
    "person":
     {"first_name": "Alvise",
      "last_name": "Sagramoso",
      "permalink": "alvise-sagramoso",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": 41000000.0,
   "price_currency_code": "USD",
   "term_code": "cash_and_stock",
   "source_url": "http://www.fiercebiotech.com/story/italys-cosmo-snap-bioxell-41m-deal/2009-11-18?utm_medium=rss\u0026utm_source=rss\u0026cmp-id=OTC-RSS-FB0",
   "source_description": "Italy's Cosmo to snap up BioXell in $41M deal",
   "acquired_year": 2009,
   "acquired_month": 11,
   "acquired_day": 18,
   "acquiring_company":
    {"name": "Cosmo Pharmaceuticals",
     "permalink": "cosmo-pharmaceuticals",
     "image":
      {"available_sizes":
        [[[150,
           60],
          "assets/images/resized/0006/6749/66749v1-max-150x150.jpg"],
         [[212,
           86],
          "assets/images/resized/0006/6749/66749v1-max-250x250.jpg"],
         [[212,
           86],
          "assets/images/resized/0006/6749/66749v1-max-450x450.jpg"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Via Fratelli Cervi, Palazzo Vasari",
    "address2": "Centro Direzionale di Milano 2",
    "zip_code": "20090",
    "city": "Segrate (MI)",
    "state_code": null,
    "country_code": "ITA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}